Survival analysis of patients with medium and advanced hepatocellular carcinoma treated by TACE combined with Endostar
To explore the effects of two different administration routes of Endostar on the survival of patients with medium and advanced hepatocellular carcinoma (HCC) and underwent trans-arterial chemoembolization (TACE). Seventy-two patients with medium and advanced HCC were enrolled. Among them, 42 patient...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2020-10-01
|
| Series: | European Journal of Inflammation |
| Online Access: | https://doi.org/10.1177/2058739220960552 |